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Summary.-The methylated purine content of tRNA bulk extracted from human
hepatomata has been compared with that in normal human liver. The analyses
were carried out with the aid of ion-exchange chromatography. The molar propor-
tions of 5 bases detected in acid hydrolysates of tumour tRNA (N2-methylguanine,
1-methylguanine, 7-methylguanine, N2-dimethylguanine and 1-methyladenine)
were not abnormally elevated.
IT HAS BEEN proposed, principally on
the basis of increased methylase activities
present in various tumours and trans-
formed cells, that the process of carcino-
genesis may be associated with excessive
or aberrant methylation of nucleic acids
(Srinivasan and Borek, 1964). Studies
on the base composition of human brain
tRNA have provided conflicting answers
to this problem (Viale, 1971; Randerath,
1971). In an attempt to provide further
data for comparison, we carried out careful
analysis of methylated purines in tRNA
bulk on the macro scale, using as starting
material human primary carcinomata
of the liver. tRNA was extracted by a
standard method (Brunngraber, 1962)
which was modified to include a step of
high speed centrifugation in 1 mol/l NaCl
(20,000 g, 30 min, 4°C) before application
of the crude nucleic acid mixture to the
DEAE column. Sephadex chromato-
graphy showed the complete elimination
of high molecular weight RNA from a
preparation thus treated (McCoy and
Carter, 1968). Each tRNA preparation
was subjected to 3 cycles oftreatment with
ribonuclease-free deoxyribonuclease (EC
3. 1 .4.5). The DNA content of the final
products was between 1-7 and 3-0%O, and
appropriate corrections were applied in
estimating the proportions of phosphorus,
adenine, guanine and cytidylic acid in
each tRNA specimen. The phosphorus
content of the final products ranged from
7*5 to 8-3%, and no protein could be
detected in the preparations. The size
ofthe tRNA sample used for each analysis
was about 150 mg.
The estimation of purines in acid
hydrolysates of tRNA was carried out by
means of chromatography on Dowex
50-H+, 200-400 mesh, on 1-2 x 57 cm
columns (Weissmann, Bromberg and Gut-
man, 1957a). tRNA specimens were
hydrolyserd at a concentration of 20 mg/ml
(N HCI, 100°C, 1 hour) and diluted with
water before application to the column.
Charging and washing of the column was
carried out with 0 05 N HCI as the solvent,
and the combined column effluents from
these steps were used for the estimation
of uridylic acid. The total volume em-
ployed for gradient elution was 4000 ml
and fractions of approximately 9 ml were
collected. The figure shows the range of
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FIG.-Separation of base constituents in a hydrolysate of tRNA by means of ion-exchange chromato-
graphy. Abbreviations: Hyp, hypoxanthine; m2Gua, N2-methylguanine; m7Gua, 7-methylguanine;
m'Gua, 1l-methylguanine; m2Gua, N2-dimethylguanine; r2Gua,N2-ribosylguanine; m'Ade, 1-methyl-
adenine; m2Ade, 2-methyladenine; m6Ade, N6-methyladenine; m6Ade, N6-dimethyladenine.
compounds examined. In preliminary
experiments, mixtures of authentic pur-
ines were subjected to chromatography
on the column, and in this manner it was
established that N6-dimethyladenine,
N6-methyladenine and 2-methyladenine
eluted after adenine in the positions
indicated. The amounts of material con-
tained in each peak were identified and
estimated using the spectral data given
by Weissmann, Bromberg and Gutman
(1957b) or those compile by Dunn and
Hall (1970). The chromMtographic pro-
files of normal and tumour tRNA con-
stituents were similar with respect to the
number and positions of the individual
peaks. The peak which appeared regu-
larly in all specimens at about fraction
50 had acid spectral ratios indistinguish-
able from those of hypoxanthine or
l-methylhypoxanthine, twb purines which
can be separated on this column (Weiss-
mann et al., 1957a). Upon concentrating
the substance and subjecting it to parti-
tioning on paper (4 N NH40H: n-butanol,
15 : 86 by vol) for 72 hours, a single spot
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was observed, which ran well behind
l-methylhypoxanthine and had a mobility
identical to that of authentic hypoxan-
thine. Recoveries of 1-methylguanine,
7-methylguanine and guanine, applied to
the column as a mixture in the proportion
1: 1: 100, were nearly quantitative. To
provide estimations ofN2-dimethylguanine
and 1-methyladenine, entire guanine and
adenine peaks were cut into fractions,
concentrated and the bases partitioned by
means of paper chromatography with the
previously specified ammoniacal butanol
for 48 hours. Identification of the minor
base in the guanine peak as N2-dimethyl-
guanine was confirmed by comparison of
its spectral ratios with those ofthe authen-
tic compound. The recovery of 1-methyl-
adenine was 44%, as judged from a sample
ofthe free base which had been mixedwith
100 times its weight of adenine and sub-
jected to- the specified conditions of
heating in acid and separation by means
of ion-exchange and paper chromato-
graphy. The reported values for this
purine have been corrected for these
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losses, which may be due in part to the
lability of this compound in hot acid
solutions (Brookes and Lawley, 1960).
Two other substances of interest were
found. Neoguanosine, a product result-
ing from acid treatment ofRNA, appeared
as a shoulder before the guanine peak
(Hemmens, 1964; Shapiro and Gordon,
1964); peak Z, a substance devoid of
phosphorus and of purine sugar, exhibited
absorbance ratios in N HCl of 0'68
(230 nm), 0-38 (240), 0-56 (250), 1P51 (270),
1*68 (280) and 1*28 (290). N6-Dimethyl-
adenine, N6-methyladenine and 2-methyl-
adenine were not detected in any of the
tRNA hydrolysates, despite exhaustive
elution ofeach column.
The analyses of methylated purines
in 4 tRNA specimens are presented in the
Table. Normal values were obtained
from duplicate estimations which were
in good agreement with each other. The
values for the individual purines were
well in line with most existing data on the
composition of mammalian tRNA. The
proportions of N2-methylguanine found
in human, hamster and HeLa cell tRNA
have been given as 1I1, 1 1 and 1 0 mol/
100 g atoms RNA-P respectively; the
values for 1-methyladenine were respec-
tively 1L1, 1L1 and 1P2 mol/100g atoms
RNA-P, and the content of N2-dimethyl-
guanine in all 3 sources was found to be
0 5 mol/100 g atoms RNA-P (cited by
Randerath, 1971). The proportions of
1-methylguanine: 1-methyladenine: 7-
methylguanine found in specimen 1 were
rather close to those found in tRNA
prepared from rat liver (Inose, Miyata
and Iwanami, 1972). The comparison of
normal with tumour tRNA was best
made with specimen 2, which was pooled
from several preparations extracted from
hepatomata. This specimen was indis-
tinguishable from normal with respect to
its content of N2-methylguanine and of
1-methylguanine. All 3 tRNA specimens
originating in cancer cases contained
abnormally low quantities of 7-methyl-
guanine and of N2-dimethylguanine.
Clearly, these data did not support the
hypothesis that tumour nucleic acids
contain increased proportions of methy-
lated bases. The failure to find hyper-
methylated tRNA in human hepatomata
confirmed a recent report on the methyl-
ated purine content oftRNA in rat ascites
hepatomata, in which a somewhat reduced
content of 7-methylguanine was recorded
(Inose et al., 1972). The observed changes
in liver tRNA composition, if related to
cancer, could not be specifically associated
with the presence of hepatocellular car-
cinoma, since the source of specimen 4
was liver which showed no malignant
changes. The proportions of N2-methyl-
TABLE Methylated Purine Content of tRNA Extracted from Normal and Pathological
Human Liver*
Source of tRNA
(No. of cases)
Normal (1)
Heptoma (6)
Hepatoma (1)
Liver from tumour-bearing
cases (2)
Mol/100 g atoms RNA phosphorus
Total
methylated
purines m2Gua m'Gua m1Ade m7Gua m2Gua
5-3 1-2 1*1 1-4 1*1 0-5
3-6 1-2 0 9 1-0 0-5 0-03
2-9 1-0 0-6 0-5 0-6 0-2
3-4 1-0 0-7 1-0 0-6 0 05
* The 5 methylated purines together with hypoxanthine and the 4 major base constituents accounted
for over 98% of the RNA phosphorus in each sample. The content of hypoxanthine in all 4 specimens was
nearly the same, about 0 33 mol/100 g atoms RNA-P. Specimen 1 was from a patient who died ofmyocardial
infarction. Specimen 4 was prepared from livers which showed no malignant changes, one taken from a
case of cancer of the ovary, and the other from a case of lung cancer. Specimen 2 contained pooled tRNA
preparations from 6 cases, and specimen 4 contained pooled tRNA from 2 cases. Characterization of the
tissue specimens was in each case made by histological examination. Yields of tRNA (g1I00 g liver)
were: specimen 1, 0-069; specimen 2, 0-020-0-091; specimen 3, 0-065; specimen 4, 0-043, 0-045.
Specimen
1
2
3
4
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guanine: 1-methyladenine: 7-methylgu-
anine found in specimens 2 and 4 were in
fact very similar to values found in the
tRNAs of cell cultures derived from
cancerous mammalian tissues (Iwanami
and Brown, 1968). The decreases in the
7-methylguanine content of the patho-
logical specimens were of some interest,
and may not be unrelated to the observa-
tion that urinary concentrations of this
base relative to creatinine appear to be
increased in some cases of cancer (Mirvish
etal., 1971).
The possibility that these results
could have been influenced by contam-
ination of specimens 2-4 with nucleic
acid poor in methylated purines was
largely eliminated by comparison of their
functional activities (Berg et al., 1961).
Specimens 1-4 incorporated respectively
005, 0.11, 010 andO05 mol amino acid
per mol tRNA. The assays employed
tRNA samples which had been pre-
viously stripped of amino acid residues
and renatured, 14C-labelled protein hydro-
lysate (Chlorella), and crude enzymes pre-
pared from E. coli B (Bergmann, Berg and
Dieckmann, 1961). The observation that
these tRNA specimens were comparable
with respect to their amino acid acceptor
ability made it very likely that the results
of the purine analyses were represent%tive
ofnormal and hepatoma tRNA.
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